On Monday (May 10), the U.S. Food and Drug Administration (FDA) extended emergency approval for the Pfizer-BioNTech COVID-19 vaccine to include adolescents between the ages of 12 and 15 years old. 

The original emergency approval, issued on Dec. 11, 2020, allowed Pfizer’s vaccine to be given to those who were 16 years of age or older.